PRESIDENT, PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION (PBOA)
"Early-stage R&D projects face longer timelines, making them less attractive when inflation remains high. If interest rates continue to decline, there could be increased investment in earlier-stage assets."
"We can now initiate projects in Budapest and conclude them at our larger-scale GMP facility in Spain and/or Mexico, offering to our customers an option for integrated project management for their programs."
"Since the establishment of our facility in the US, we have felt the appreciation of the market in being able to have a local partner, especially in light of many companies trying to localize their supply chains."
PRESIDENT AND GENERAL MANAGER, RLDATIX LIFE SCIENCES
"RLDatix is a one-stop-shop offering comprehensive solutions to navigate critical operational and compliance challenges in the life sciences industry."
"We have large and growing volumes of missing diagnostics and therapeutics that never even go through the pharma pipeline, not to mention the growing number of neglected products languishing in the development pipeline."
GLOBAL BUSINESS UNIT DIRECTOR (KS) AND SENIOR VP MARKETING CORPORATE DEVELOPMENT (AC), COLD CHAIN TECHNOLOGIES (CCT)
"By focusing on performance, cost-effectiveness, compliance, sustainability, and visibility, we help our pharmaceutical customers achieve the optimal balance in their thermal packaging solutions."
Featuring insights from nearly 50 mining executives, the second pre-release edition of GBR's Peru Mining 2025 sheds light on the industry's current state while highlighting the country's window of opportunity with the energy transition and copper's critical role.